BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 361438)

  • 1. Chemical characterization of products of activated lymphocytes.
    Sorg C; Klinkert W
    Fed Proc; 1978 Nov; 37(13):2748-53. PubMed ID: 361438
    [No Abstract]   [Full Text] [Related]  

  • 2. A sensitive technique for measuring specific macrophage aggregation: a comparison with macrophage migration inhibition, for the detection of lymphokine activity.
    Rouveix B; Badenoch-Jones P; Turk JL
    Immunology; 1979 Mar; 36(3):589-94. PubMed ID: 374256
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Guinea pig lymphocyte-derived macrophage aggregation factor: its separation from macrophage migration inhibitory factor.
    Postlethwaite AE; Kang AH
    J Immunol; 1976 Nov; 117(5 Pt 1):1651-5. PubMed ID: 794415
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Chemical mediator, lymphokine, produced by activated lymphocytes].
    Morisawa S
    Nihon Rinsho; 1978; 36(5):937-43. PubMed ID: 353329
    [No Abstract]   [Full Text] [Related]  

  • 5. Spontaneous MIF secretion by peripheral lymphocytes of cancer patients.
    Waldman RH; Ganguly R; Cusumano CL
    J Reticuloendothel Soc; 1978 May; 23(5):335-41. PubMed ID: 353280
    [No Abstract]   [Full Text] [Related]  

  • 6. Studies on experimental pulmonary granulomas. I. Detection of lymphokines in granulomatous lesions.
    Masih N; Majeska J; Yoshida T
    Am J Pathol; 1979 May; 95(2):391-406. PubMed ID: 377991
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of two lymphokines (macrophage migration inhibition, leukocyte adherence inhibition factors) and carcinoembryonic antigen, in colorectal cancer and colonic premalignant lesions.
    Shkolnik T; Livni E; Reshef R; Lachter J; Eidelman S
    Am J Gastroenterol; 1987 Dec; 82(12):1275-8. PubMed ID: 3318403
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Isolation and testing of factors affecting macrophage and leukocyte migration].
    Gankovskaia LV; Gvozdeva NA; Moskvina SN
    Lab Delo; 1986; (10):612-4. PubMed ID: 2432322
    [No Abstract]   [Full Text] [Related]  

  • 9. Production of leucocyte inhibitory factor (LIF) and macrophage inhibitory factor (MIF) by PHA-stimulated lymphocytes.
    Ruthlomnitzer ; Rabson AR; Koornhof HJ
    Clin Exp Immunol; 1975 Dec; 22(3):522-7. PubMed ID: 773578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Detection of the macrophage migration inhibitory factor as a possible measure of sensitization to seminal antigens (author's transl)].
    Mettler L; Scheidel P
    Geburtshilfe Frauenheilkd; 1974 Mar; 34(3):157-63. PubMed ID: 4600994
    [No Abstract]   [Full Text] [Related]  

  • 11. Leukocyte migration inhibitory factor (LMIF) profile in primary and secondary immunodeficiency disease.
    Górski AJ; Dupont B; Hansen JA; O'Reilly R; Smithwick E; Górska R; Good RA
    Clin Exp Immunol; 1976 Dec; 26(3):505-10. PubMed ID: 795576
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inflammatory, non-antibody lymphocytic mediators (lymphokines).
    Bendtzen K; Bendixen G
    Allerg Immunol (Leipz); 1980; 26(4):293-309. PubMed ID: 6163346
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional characteristics of histamine receptor-bearing mononuclear cells. I. Selective production of lymphocyte chemoattractant lymphokines with histamine used as a ligand.
    Center DM; Cruikshank WW; Berman JS; Beer DJ
    J Immunol; 1983 Oct; 131(4):1854-9. PubMed ID: 6352807
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inflammatory mediators in culture filtrates of Escherichia coli.
    Yoshida T; Cohen S; Bigazzi PE; Kurasuji T; Amsden A
    Am J Pathol; 1975 Nov; 81(2):389-400. PubMed ID: 1103632
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of human T cell production of migration inhibitory lymphokines by cytokines derived from human leukocyte dialysates.
    Gottlieb AA; Farmer JL; Matzura CT; Hester RB; Rosenberg JS
    J Immunol; 1984 Jan; 132(1):256-60. PubMed ID: 6361122
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of human macrophage activation factor (MAF) prepared from antigen-stimulated lymphocytes.
    Cameron DJ
    J Clin Lab Immunol; 1984 Jan; 13(1):47-50. PubMed ID: 6371237
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Production of MIF-like supernatants by rheumatoid arthritis lymphocytes stimulated by immunoglobulin G.
    Sany J; Mathieu O; Clot J; Mandin J; Serre H
    Rheumatology; 1975; 6():131-8. PubMed ID: 1105742
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Systemic cellular mediated immunity in children hospitalized with clinical, virological and serological diagnosis of Coxsackie B virosis].
    Voiculescu C; Stanciu L; Nedelcu C; Rogoz S; Dimitriu I; Tăţulescu M
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Bacteriol Virusol Parazitol Epidemiol; 1981; 26(4):235-41. PubMed ID: 6276961
    [No Abstract]   [Full Text] [Related]  

  • 19. Production and partial characterization of dog macrophage migration inhibitory factor.
    Schnizlein CT; Bice DE
    J Reticuloendothel Soc; 1980 Apr; 27(4):393-400. PubMed ID: 6989994
    [No Abstract]   [Full Text] [Related]  

  • 20. Partial purification and physicochemical properties of human T cell migration inhibitory factor (TIF).
    Kowalczyk D; Staykowa M; Litwora E; Pryjma J; Zembala M
    J Clin Lab Immunol; 1984 Oct; 15(2):105-10. PubMed ID: 6394762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.